Holdings A/S Novo - Feb 8, 2024 Form 3 Insider Report for Metagenomi Technologies, LLC (MGX)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations
Stock symbol
MGX
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
3
Date filed
2/8/2024, 08:37 PM
Previous filing
Aug 11, 2023
Next filing
Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MGX SERIES B PREFERRED STOCK Feb 8, 2024 COMMON STOCK 147K Direct F1
holding MGX SERIES B-1 PREFERRED STOCK Feb 8, 2024 COMMON STOCK 692K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Preferred Stock and Series B-1 Preferred Stock is convertible into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.